|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date01 Jan 1990 |
|
|
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1980 |
左乙拉西坦缓释片添加治疗癫痫部分性发作的有效性和安全性的多中心、随机、双盲、安慰剂平行对照临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of levetiracetam extended-release tablets as an add-on treatment for partial-onset epileptic seizures
以安慰剂为对照,评价左乙拉西坦缓释片添加治疗癫痫部分发作的有效性和安全性。
[Translation] To evaluate the efficacy and safety of levetiracetam extended-release tablets as an add-on treatment for partial-onset epileptic seizures, compared with placebo.
盐酸头孢替安酯片治疗轻、中度呼吸和泌尿系统急性细菌感染的 随机、双盲、阳性药平行对照、多中心临床试验
[Translation] A randomized, double-blind, positive-drug parallel-controlled, multicenter clinical trial of ceftriaxone hydrochloride tablets in the treatment of mild and moderate acute bacterial infections of the respiratory and urinary systems
以头孢呋辛酯片为对照,评价盐酸头孢替安酯片治疗轻、中度呼吸和泌尿系统急性细菌感染的有效性和安全性
[Translation] To evaluate the efficacy and safety of cefuroxime axetil tablets in the treatment of mild and moderate acute bacterial infections of the respiratory and urinary systems, using cefuroxime axetil tablets as a control.
评价受试制剂阿戈美拉汀片25 mg和参比制剂维度新在中国男性健康受试者中的生物等效性研究
[Translation] A study to evaluate the bioequivalence of the test preparation agomelatine tablets 25 mg and the reference preparation Weiduxin in healthy Chinese male subjects
比较受试制剂阿戈美拉汀片25 mg(瑞阳制药有限公司)与参比制剂维度新(阿戈美拉汀片25 mg,法国施维雅药厂)的人体药代动力学参数,评价受试制剂与参比制剂间的生物等效性。
[Translation] The pharmacokinetic parameters of the test preparation agomelatine tablets 25 mg (Ruiyang Pharmaceutical Co., Ltd.) and the reference preparation Weiduxin (agomelatine tablets 25 mg, Servier Pharmaceuticals, France) were compared to evaluate the bioequivalence between the test preparation and the reference preparation.
100 Clinical Results associated with Beijing Boshi Antai Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Boshi Antai Technology Development Co., Ltd.
100 Deals associated with Beijing Boshi Antai Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Boshi Antai Technology Development Co., Ltd.